The Indonesian health sector iscurrently experiencing a financing transition that will havea profound impact on the country's efforts to achieveuniversal health coverage (UHC) and national health goals.The transition is marked, on the one hand, by increasing percapita expenditure on health and, on the other, by decliningof out-of-pocket payments (OOP) and a significant reductionof external funding for health as a source of healthfinancing. Assuming steady economic growth, Indonesia issoon projected to greatly reduce or transition from itsreliance on external financing for the national AIDS,Tuberculosis (TB), Malaria, and Childhood Immunization(ATMI) programs. While varying somewhat from program toprogram, the extent of financial transition required will besubstantial for all four programs. Complicating thetransition process is the fact that all four programs arecurrently engaged in making significant changes in programstrategies and implementation processes in response to bothunderperformance and Indonesia's commitment to reachingglobal targets.